Literature DB >> 2901434

Inference of a molecular defect of apolipoprotein B in hypobetalipoproteinemia by linkage analysis in a large kindred.

M Leppert1, J L Breslow, L Wu, S Hasstedt, P O'Connell, M Lathrop, R R Williams, R White, J M Lalouel.   

Abstract

Heterozygous hypobetalipoproteinemia is characterized by reduced plasma concentrations of LDL cholesterol, total triglycerides, and apo B to less than 50% of normal values. The molecular basis of this disorder remains unknown. The phenotype cosegregates with a DNA haplotype of the apo B gene in an Idaho pedigree, with a maximum decimal logarithm of the ratio (LOD) score of 7.56 at a recombination rate of zero. Individuals carrying this haplotype had total cholesterol levels of 96 mg/dl, LDL cholesterol levels of 37 mg/dl, triglycerides levels of 51 mg/dl, and apo B levels of 38 mg/dl. This study strongly suggests that apo B mutations underlie hypobetalipoproteinemia, and demonstrates the power of the candidate gene approach in linkage analysis for unraveling genetic determinants in metabolic disorders of undefined etiology.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901434      PMCID: PMC303592          DOI: 10.1172/JCI113688

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Turnover of apolipoprotein-B in two subjects with familial hypobetalipoproteinemia.

Authors:  G Sigurdsson; A Nicoll; B Lewis
Journal:  Metabolism       Date:  1977-01       Impact factor: 8.694

2.  RFLP for the human apolipoprotein B gene: I;BamHI.

Authors:  L Priestley; T Knott; S Wallis; L Powell; R Pease; A Simon; J Scott
Journal:  Nucleic Acids Res       Date:  1985-09-25       Impact factor: 16.971

3.  Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3.

Authors:  G R Warnick; C Mayfield; J J Albers; W R Hazzard
Journal:  Clin Chem       Date:  1979-02       Impact factor: 8.327

4.  Polymorphic DNA region adjacent to the 5' end of the human insulin gene.

Authors:  G I Bell; J H Karam; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

5.  Isolation and regional localization of DNA segments revealing polymorphic loci from human chromosome 13.

Authors:  W Cavenee; R Leach; T Mohandas; P Pearson; R White
Journal:  Am J Hum Genet       Date:  1984-01       Impact factor: 11.025

6.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

7.  Rapid transfer of DNA from agarose gels to nylon membranes.

Authors:  K C Reed; D A Mann
Journal:  Nucleic Acids Res       Date:  1985-10-25       Impact factor: 16.971

8.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Evidence that men with familial hypercholesterolemia can avoid early coronary death. An analysis of 77 gene carriers in four Utah pedigrees.

Authors:  R R Williams; S J Hasstedt; D E Wilson; K O Ash; F F Yanowitz; G E Reiber; H Kuida
Journal:  JAMA       Date:  1986-01-10       Impact factor: 56.272

10.  Human apolipoprotein B cDNA clone isolation and demonstration that liver apolipoprotein B mRNA is 22 kilobases in length.

Authors:  L S Huang; S C Bock; S I Feinstein; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more
  9 in total

Review 1.  Genetic basis of lipoprotein disorders.

Authors:  J L Breslow
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

2.  Sample-size guidelines for linkage analysis of a dominant locus for a quantitative trait by the method of lod scores.

Authors:  M Boehnke
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

3.  Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the formation of buoyant, triglyceride-rich lipoproteins.

Authors:  S G Young; S T Hubl; R S Smith; S M Snyder; J F Terdiman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

4.  The polymorphism ApoB/4311 in patients with myocardial infarction and controls: the ECTIM Study.

Authors:  J F Moreel; G Roizes; A E Evans; D Arveiler; J P Cambou; C Souriau; H J Parra; E Desmarais; J C Fruchart; P Ducimetière
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

5.  Exclusion of linkage between the human apolipoprotein B gene and abetalipoproteinemia.

Authors:  L S Huang; P A Jänne; J de Graaf; M Cooper; R J Deckelbaum; H Kayden; J L Breslow; R J Decklebaum
Journal:  Am J Hum Genet       Date:  1990-06       Impact factor: 11.025

Review 6.  Apolipoprotein genes and atherosclerosis.

Authors:  J L Breslow
Journal:  Clin Investig       Date:  1992-05

Review 7.  Gene-environment interactions in atherosclerosis.

Authors:  R A Hegele
Journal:  Mol Cell Biochem       Date:  1992-08-18       Impact factor: 3.396

8.  Anderson's disease: genetic exclusion of the apolipoprotein-B gene in two families.

Authors:  M Pessah; P Benlian; I Beucler; N Loux; J Schmitz; C Junien; R Infante
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

9.  The Holstein Friesian Lethal Haplotype 5 (HH5) Results from a Complete Deletion of TBF1M and Cholesterol Deficiency (CDH) from an ERV-(LTR) Insertion into the Coding Region of APOB.

Authors:  Ekkehard Schütz; Christin Wehrhahn; Marius Wanjek; Ralf Bortfeld; Wilhelm E Wemheuer; Julia Beck; Bertram Brenig
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.